12. Allowed concomitant medications should be maintained on a stable dose from screening until the end of the study. Stable regular doses of dihydropyridines, such as amlodipine (Norvasc), to control blood pressure are permitted. (However, cardiovascular drugs that are taken as prn that could affect the blood flow centrally are excluded).